PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
27694321-0	2016	Inverse agonism at the P2Y12 receptor and ENT1 transporter blockade contribute to platelet inhibition by ticagrelor.	Ticagrelor	105-115	solute carrier family 29 member 1 (Augustine blood group)	Homo sapiens	42-46	
27694321-4	2016	This additional effect of ticagrelor beyond P2Y12R antagonism was in part as a consequence of ticagrelor inhibiting the equilibrative nucleoside transporter 1 (ENT1) on platelets, leading to accumulation of extracellular adenosine and activation of Gs-coupled adenosine A2A receptors.	Ticagrelor	26-36	solute carrier family 29 member 1 (Augustine blood group)	Homo sapiens	120-158	
27694321-4	2016	This additional effect of ticagrelor beyond P2Y12R antagonism was in part as a consequence of ticagrelor inhibiting the equilibrative nucleoside transporter 1 (ENT1) on platelets, leading to accumulation of extracellular adenosine and activation of Gs-coupled adenosine A2A receptors.	Ticagrelor	26-36	solute carrier family 29 member 1 (Augustine blood group)	Homo sapiens	160-164	
27694321-4	2016	This additional effect of ticagrelor beyond P2Y12R antagonism was in part as a consequence of ticagrelor inhibiting the equilibrative nucleoside transporter 1 (ENT1) on platelets, leading to accumulation of extracellular adenosine and activation of Gs-coupled adenosine A2A receptors.	Ticagrelor	94-104	solute carrier family 29 member 1 (Augustine blood group)	Homo sapiens	120-158	
27694321-4	2016	This additional effect of ticagrelor beyond P2Y12R antagonism was in part as a consequence of ticagrelor inhibiting the equilibrative nucleoside transporter 1 (ENT1) on platelets, leading to accumulation of extracellular adenosine and activation of Gs-coupled adenosine A2A receptors.	Ticagrelor	94-104	solute carrier family 29 member 1 (Augustine blood group)	Homo sapiens	160-164	
27694321-11	2016	In summary, our studies describe 2 novel modes of action of ticagrelor, inhibition of platelet ENT1 and inverse agonism at the P2Y12R that contribute to its effective inhibition of platelet activation.	Ticagrelor	60-70	solute carrier family 29 member 1 (Augustine blood group)	Homo sapiens	95-99